A股異動 | 金剛玻璃(300093.SZ)跌逾6% 收深交所關注函
格隆匯1月26日丨金剛玻璃(300093.SZ)現報28.94元,跌6.1%,暫成交2億元,最新市值62億元。昨日,深交所向廣東金剛玻璃科技股份有限公司發關注函,對金剛玻璃前期披露的增持計劃進行了問詢,要求説明公司增持計劃是否具備可行性,增持決策是否審慎,是否存在通過延期以規避履行承諾、誤導投資者以及炒作股價的情形。據悉,金剛玻璃曾於1月24日公佈,歐昊集團擬變更增持計劃,一是將增持計劃截止時間由2022年2月24日延長至2023年2月24日,二是增持主體由歐昊集團變更為歐昊集團及其一致行動人,三是增持數量由2600萬股變更為2000萬股。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.